Target intelligence / Profile preview

Pathogen-associated Replikin peptide motifs (Replikin)

Target
Replikin
Molecular classification
Peptide motif, Protein sequence motif
01

Overview

Pathogen-associated Replikin peptide motifs are a class of short, conserved amino acid sequences characterized by a specific arrangement of lysine and histidine residues. Specifically, a Replikin is defined as a sequence of 7 to 50 amino acids containing at least two lysines 6 to 10 residues apart, at least one histidine, and a total lysine content of at least 6% (7). These motifs are claimed to be quantitatively associated with the rapid replication rates of various pathogens, including influenza viruses, SARS-CoV, and Zika virus, as well as malignant cancer cells (3, 4, 5). Therapeutic strategies targeting these motifs involve the development of synthetic peptide vaccines and antibodies designed to disrupt the replication cycle (1, 2). Despite being the basis for several experimental vaccines and diagnostic tests like the Antimalignin Antibody in Serum (AMAS) test, the Replikin concept remains controversial and is not widely accepted in mainstream molecular biology due to a perceived lack of rigorous mechanistic evidence (9, 10).

Other names
Replikin sequencesReplikin motifsReplikin structuresGenomic Replikins
02

Mechanism of action

Inhibition of rapid replication by targeting conserved lysine- and histidine-rich motifs claimed to be essential for the replication cycle of pathogens and malignant cells.

03

Biological functions

Viral replicationCell proliferationPathogen virulence
04

Disease associations

InfectionCancerInfluenzaSevere acute respiratory syndrome (SARS)Zika virus infectionEbola virus disease
05

Safety considerations

Lack of mainstream clinical validationPotential for off-target effects due to the commonality of lysine and histidine residuesScientific skepticism regarding the functional significance of the motif
06

Interacting drugs

Replikin H5N1 Bird Flu Vaccine

3 more in the full profile.

07

Biomarkers

Replikin CountAntimalignin Antibody in Serum (AMAS)

Beyond the preview

Go deeper on Pathogen-associated Replikin peptide motifs (Replikin).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogen-associated Replikin peptide motifs (Replikin).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call